Unblinded study medication for better clinical trials
Providing subjects with unblinded medication in studies and supplies is fraught with difficulty. Clinical Trials Insight examines how…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jan 18
Providing subjects with unblinded medication in studies and supplies is fraught with difficulty. Clinical Trials Insight examines how…
11 Jan 18
With sophisticated technology making it more accessible than ever, real-world data has the potential to transform how clinical…
11 Jan 18
Ambitious new EU guidance on transparency and disclosure aims to boost public trust, but it faces an industry-wide…
11 Jan 18
The overwhelming majority of pharmaceuticals fail when tested on humans, particularly in oncology, where 95% of drugs tested…
11 Jan 18
Tight budgets mean that combining the forces of academia’s innovation with pharma’s resources is happening with increasing frequency.…
11 Jan 18
Balancing risk and cost is a delicate undertaking where controlled room temperature clinical trial shipments are concerned. Lisbeth…
11 Jan 18
Jeff Yant, executive director of global operations at Amgen Biosimilars, discusses the challenges of producing and managing biosimilars.…
11 Jan 18
Risk-based monitoring can promote more efficient data standardisation and speed up clinical trial timelines. Kerry Taylor-Smith speaks to…
11 Jan 18
The digital age is upon us, yet many clinical trials are still rooted in cumbersome paper-based procedures. An…
11 Jan 18
Dr Sanjay Sethi is a leading clinical trials manager in CPOD from the University of Buffalo, with a…